ICER's mission is to lead innovation in comparative effectiveness research through methods that integrate considerations of clinical benefit and economic value. Through a unique collaboration with patients, clinicians, manufacturers, insurers and other healthcare stakeholders, ICER develops tools to support patient decisions and medical policy that share the goal of achieving maximum value for every healthcare dollar.
| Final CCTA Appraisal now available, Jan 2009 |
| The final appraisal document, "CCTA Final Appraisal - Full Report" is now available on the ICER website. |